California psychedelics legalization bill advances, Kentucky to spend $42 million on ibogaine research; DC’s psychedelics lobbyists; Is informed consent possible?
UK Members of Parliament call for psilocybin rescheduling, a new psychedelics Action Group in the European Parliament, and was Australia’s psychedelic reform “too fast and too soon”?
American Medical Association assigns billing code for psychedelic therapy; Can psychedelics alter colorblindness?; How should Oregon collect data on psilocybin service users?
The latest in Colorado, new study suggests single psilocybin session could reduce depressive symptoms in cancer patients, and MindMed announces preliminary results, stock soars